Walgreens recently settled a class action lawsuit, potentially putting cash in the pockets of Americans who faced job denials due to background checks. The settlement, a result of alleged Fair Credit Reporting Act violations, offers up to $918.28 to affected individuals. While Walgreens didn’t admit fault, it agreed to pay an undisclosed sum.
If you applied to work at Walgreens between March 30, 2020, and May 17, 2022, and were turned down because of background checks, you could be eligible for compensation. The deadline for exclusion and objection is May 23, with the final hearing scheduled for July 23.
This settlement comes amid a series of challenges for Walgreens. The company announced the closure of 150 stores in 2023 and faces tough economic conditions, with over 3,000 retail closures expected industry-wide by the end of 2024. Rite Aid, another pharmacy chain, filed for bankruptcy in 2023, citing operational and financial woes.
On a different legal front, Americans may also be entitled to $300 in a telemarketing lawsuit settlement against the Chicago Cubs. If you received unwanted marketing texts from the Cubs after May 2, 2019, you could claim compensation.
Last month, Walgreens expanded its pharmacy services by collaborating with drug manufacturers to offer cell and gene therapies to patients in the U.S. The company launched a new business unit within its pharmacy sector and integrated specialty pharmacy subsidiary AllianceRx. Specialty pharmacies were key players in managing medications for chronic, rare, or complex conditions.
Walgreens invested in a licensed facility in Pittsburgh for cell and gene therapies to support drugmakers and healthcare providers in navigating the supply chain for these treatments. The move came in response to the increasing approvals for cell and gene therapies in the U.S. and EU. Walgreens aimed to become a leading provider of specialty pharmacy services and maintain flexibility in contracting with payers and pharmaceutical manufacturers.
Leave a Comment